EBRO 2017

Diagnostic work-up

EBRO 2017

M staging: PET-CT

Detection of occult metastases • Initial studies using FDG PET: • Metastatic disease detected in 15% patients considered potentially resectable*. • Prospective trial 187 patients showed confirmed up- staging in 18 (9.5%) patients with unconfirmed metastases ‡ • 25/156 (16%) patients up staged to M1b disease on PET- CT § *Flamen, P., A. Lerut, et al. (2000). J Clin Oncol 18 (18): 3202 -10

‡ Meyers, B. F., R. J. Downey, et al. (2007). J Thorac Cardiovasc Surg 133 (3): 738 -45 § Purandare, N. C., C. S. Pramesh, et al. (2014). Nucl Med Commun 35 (8): 864-869